The FDA issued a correction related to a recall of Boston Scientific (NYSE:BSX) defibrillation leads, labeling it the most serious kind.

Tidying up your flat, playing music to suit your mood, waking you up in the morning, opening the door, turning on the light, ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second ...

Tempus AI's Tempus Pixel received FDA clearance for cardiac imaging updates, adding T1/T2 maps to enhance MR image analysis ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory ...

In the latest episode of the Alleima Medical podcast, a panel of industry explore thermocouples – tiny temperature sensors ...

Artrya (ASX:AYA) is seeking to raise $80 million in placement and share purchase plan to support rollout of its heart disease diagnosis tools.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) is a medical device company specializing in products for peripheral vascular disease, ...

We recently published 10 Stocks Investors Are Gobbling Up. Tempus AI, Inc. (NASDAQ:TEM) is one of the best performers on ...

A PS contributor tried Eternal and a 2.5-hour grueling fitness test that pushes you to the max. Here are her takeaways and ...

UK study finds AI stethoscope detects major heart conditions in seconds, helping GPs diagnose earlier without advanced tests.

Cardiac mappers are experts in the cardiac arrhythmia ablation procedure, which requires technical knowledge of the procedure ...